newsfilter
← Latest News
Business Wire·

Janux Therapeutics to Host Virtual R&D Day on July 24, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell